Categories AlphaGraphs, Earnings, Health Care

VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an increase in revenues.

Vertex Pharmaceuticals Q1 2023 earnings infographic

Total revenues increased to $2.37 billion in the first quarter from $2.10 billion in the corresponding period of 2022. For the full fiscal year, the management expects product revenues to be between $9.55 billion and $9.70 billion.

Meanwhile, adjusted earnings dropped to $3.05 per share in the March quarter from $3.52 per share in the prior-year period. Unadjusted profit was $699.8 million or $2.69 per share, compared to $762.1 million or $2.96 per share last year.

Prior Performance

  • Vertex-Pharmaceuticals-Q4-2022-Earnings-Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

LLY Earnings: Eli Lilly Q4 2024 profit more than doubles; revenue up 45%

Eli Lilly and Company (NYSE: LLY) Thursday reported a sharp increase in its fourth-quarter revenues. The pharmaceutical company's adjusted earnings more than doubled during the quarter. Worldwide revenue increased 45%

Ford Motor Company (F) Earnings: 4Q24 Key Numbers

Ford Motor Company (NYSE: F) reported revenue of $48.2 billion for the fourth quarter of 2024, up 5% year-over-year. GAAP net income was $1.8 billion, or $0.45 per share, compared

Philip Morris (PM) Q4 2024 Earnings: Key financials and quarterly highlights

Philip Morris International Inc. (NYSE: PM) reported its fourth quarter 2024 earnings results today. Net revenues increased 7.3% year-over-year to $9.7 billion. Organic revenue growth was also 7.3%. Net loss attributable

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top